Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2011-05-10
2011-05-10
Wax, Robert A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
Reexamination Certificate
active
07939102
ABSTRACT:
Rapidly disintegrating multiparticulate controlled release formulations of lamotrigine having an improved pharmacokinetic profile and improved patient compliance, and process of preparing the formulations. It provides better control of blood plasma levels than conventional tablet formulations that is administered once or more times a day.
REFERENCES:
patent: 5326570 (1994-07-01), Rudnic et al.
patent: 5536507 (1996-07-01), Abramowitz et al.
patent: 5556639 (1996-09-01), Fielden
patent: 5637320 (1997-06-01), Bourke et al.
patent: 5863558 (1999-01-01), Jao et al.
patent: 6194000 (2001-02-01), Smith et al.
patent: 6627223 (2003-09-01), Percel et al.
patent: 2002/0012675 (2002-01-01), Jain et al.
patent: 2004/0192690 (2004-09-01), Buxton et al.
patent: 2005/0032799 (2005-02-01), Buxton et al.
patent: WO 92/13527 (1992-08-01), None
patent: WO 97/14415 (1997-04-01), None
patent: WO03090693 (2003-11-01), None
Nadkarni Sunil Sadanand
Vaya Navin
Barham Bethany
Costigan James V.
Hedman & Costigan ,P.C.
Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Torrent Research Center
LandOfFree
Controlled release formulation of lamotrigine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release formulation of lamotrigine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulation of lamotrigine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2632230